Understanding Wet and Dry Macular Degeneration: Key Differences Explained
Age-related macular degeneration (AMD) is a leading cause of central vision loss for people over 50, and it appears in two primary forms: wet and dry macular degeneration. Understanding the differences between the two is important for early recognition, timely diagnosis and appropriate management. While both types affect the macula—the small central portion of the retina responsible for sharp, detailed vision—their underlying mechanisms, pace of progression and treatment options diverge significantly. This article explains the distinguishing features of wet and dry macular degeneration, how they present clinically, typical diagnostic tests and the current standard approaches to care and monitoring. Readers should gain a clearer sense of what to watch for, what tests an eye care specialist may order, and the practical next steps for preserving vision and accessing supportive services without relying on technical jargon.
What causes wet and dry macular degeneration, and who is at risk?
Both wet and dry macular degeneration are forms of age-related macular degeneration and share several risk factors, including older age, family history, smoking, hypertension and a history of cardiovascular disease. Dry macular degeneration, or atrophic AMD, develops when light-sensitive cells in the macula gradually break down and pigment changes and drusen (small yellow deposits) accumulate beneath the retina. Wet macular degeneration, or neovascular AMD, arises when abnormal blood vessels grow under the retina and macula, leaking fluid or blood and causing relatively rapid central vision loss. Genetic predisposition and lifestyle contributors—particularly smoking and poor dietary patterns—can increase the likelihood of progression from early dry changes to more advanced dry or to the wet form. Understanding these risk factors helps prioritize screening and modifiable behaviors that can reduce overall risk.
How do symptoms and vision loss differ between the wet and dry types?
Symptoms overlap but often follow distinct patterns. Dry macular degeneration more commonly causes gradual blurring of central vision, difficulty reading fine print, colors appearing less vivid and mild distortions that progress slowly over months to years. Patients with dry macular degeneration frequently notice fading of central detail while peripheral vision remains intact. By contrast, wet macular degeneration tends to produce more sudden or rapid changes in central vision because of bleeding or fluid leakage from abnormal vessels. Typical signs of wet disease include a sudden onset of a dark or blind spot in the center of vision, markedly distorted straight lines (metamorphopsia) and rapid decline in reading ability. Early detection of sudden changes is critical, because some treatments for wet AMD can slow or stabilize vision loss if started promptly.
What tests are used to diagnose wet versus dry macular degeneration?
Diagnosing either form starts with a comprehensive eye exam by an ophthalmologist or retinal specialist, including visual acuity testing and an Amsler grid to screen for central distortion. Optical coherence tomography (OCT) is a noninvasive imaging test that provides cross-sectional views of the retina and can show drusen, thinning, fluid accumulation or retinal swelling—key findings that help distinguish dry from wet disease. Fluorescein angiography and indocyanine green angiography are invasive imaging studies that may be used when wet macular degeneration is suspected; they map blood flow and identify leaking or abnormal vessels. In routine monitoring, OCT is the preferred tool for tracking progression, assessing treatment response and guiding decisions about anti-VEGF injections or other interventions.
Treatment options: how management differs between wet and dry AMD
Treatment strategies contrast sharply between the two types. For wet macular degeneration, anti-VEGF (vascular endothelial growth factor) injections into the eye are the mainstay of therapy; these medications reduce abnormal vessel growth and leakage, and many patients experience stabilization or partial improvement in central vision with regular treatment. Photodynamic therapy and, less commonly, laser therapy are additional options in selected cases. For dry macular degeneration, there is no widely effective treatment to reverse retinal cell loss, but evidence-based measures can slow progression: high-dose antioxidant and mineral supplements formulated under AREDS and AREDS2 study protocols for appropriate patients, smoking cessation, blood pressure control and a diet rich in leafy greens, omega-3s and carotenoids. Low vision aids, rehabilitation services and clinical trial enrollment are important components of comprehensive care for both forms, particularly as research continues into new pharmacologic and gene-based therapies.
| Feature | Dry Macular Degeneration | Wet Macular Degeneration |
|---|---|---|
| Prevalence | More common (majority of AMD cases) | Less common but accounts for most severe vision loss |
| Pathology | Drusen, gradual retinal atrophy | Abnormal blood vessel growth, leakage/bleeding |
| Onset | Slow, progressive | Often sudden or rapid |
| Common symptoms | Blurry central vision, faded colors | Dark spot, sudden distortion, rapid vision loss |
| Key diagnostic tests | OCT, fundus exam | OCT, fluorescein angiography, fundus exam |
| Treatment | AREDS supplements, lifestyle, monitoring | Anti-VEGF injections, possible photodynamic therapy |
| Prognosis | Slow decline; variable course | Higher risk of rapid central vision loss without treatment |
How to reduce risk and live well with macular degeneration
Prevention and daily management focus on evidence-backed lifestyle choices and regular monitoring. Stopping smoking is the single most effective modifiable step to lower progression risk, while maintaining cardiovascular health, controlling blood pressure, and adopting a diet high in leafy vegetables, fish and reduced processed foods supports retinal health. For those already diagnosed, routine eye exams and self-monitoring—using tools like the Amsler grid at home—help detect changes that require prompt attention. Low vision specialists can recommend magnification devices, adaptive lighting and digital accessibility tools to preserve independence. Participation in registries or clinical trials may provide access to emerging macular degeneration treatments, and support groups can help with emotional coping and practical tips for daily living.
What to do next if you notice changes in your vision
If you experience new distortion, dark areas in central vision or a rapid drop in clarity, contact an eye care professional promptly for evaluation; fast action is particularly important when wet macular degeneration is suspected because treatments are time-sensitive. For routine care, schedule periodic retinal imaging and discuss whether AREDS supplements are appropriate for your stage of dry AMD. Keep a record of your visual acuity and any symptoms, avoid smoking, protect your eyes from excessive UV exposure and maintain heart-healthy habits. This information is intended to inform and support conversations with qualified eye care providers and should not replace individualized medical evaluation or treatment. If you have sudden vision changes, seek urgent ophthalmic care without delay.
This text was generated using a large language model, and select text has been reviewed and moderated for purposes such as readability.
